A cohort study of gastric-type adenocarcinoma (GAS) of the uterine cervix: Multi-institutional study by Gynecologic Cancer Study Group of the Japan Clinical Oncology Group (JCOG).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5595-5595
Author(s):  
Shin Nishio ◽  
Yoshiki Mikami ◽  
Takeo Otsuki ◽  
Nobuo Yegashi ◽  
Toyomi Satoh ◽  
...  
Keyword(s):  
Cohort Study ◽  
Clinical Oncology ◽  
Uterine Cervix ◽  
Gynecologic Cancer ◽  
Study Group ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Cancer Study ◽  
Cancer Study Group ◽  
Gastric Type

scholarly journals Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG)

2020 ◽  
Vol 50 (4) ◽  
pp. 368-378 ◽  
Author(s):  
Akira Ouchi ◽  
Dai Shida ◽  
Tetsuya Hamaguchi ◽  
Atsuo Takashima ◽  
Yoshinori Ito ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Treatment Outcomes ◽  
Clinical Oncology ◽  
Early Stage ◽  
Study Group ◽  
Oncology Group ◽  
Perioperative Treatment ◽  
Cancer Study ◽  
Improve Treatment ◽  
Cancer Study Group

Abstract Colorectal cancer is a major public health concern in Japan. While early-stage colorectal adenocarcinoma treatment entails radical resection of the primary tumor, the importance of perioperative treatment is growing as physicians seek to further improve treatment outcomes. For anal squamous cell carcinoma, definitive chemoradiotherapy is superior to radical surgery in terms of improved patient quality of life. The Colorectal Cancer Study Group of the Japanese Clinical Oncology Group was established in 2001 and has worked to provide answers to common clinical questions and improve treatment outcomes for colorectal and anal cancers through 15 large-scale prospective clinical trials. Here, we discuss the current state of perioperative treatment for early-stage colon, rectal and anal cancers in Japan and approaches taken by the Colorectal Cancer Study Group/the Japanese Clinical Oncology Group to improve treatment outcomes for these cancers.

scholarly journals History of Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group

2020 ◽  
Vol 50 (5) ◽  
pp. 502-511
Author(s):  
Hidehito Horinouchi ◽  
Yuichiro Ohe
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Oncology ◽  
Small Cell ◽  
Study Group ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Japan Clinical Oncology Group ◽  
Cancer Study Group ◽  
Lung Cancer Study Group

Abstract The Japan Clinical Oncology Group Lung Cancer Study Group has been carrying out clinical studies, exploring new strategies of treatment, supportive therapies (antiemetics, etc.), etc., for a variety of cancers, including not only small cell lung cancer and non-small cell lung cancer but also rare chest tumours (represented by thymoma) and cancer-associated conditions (cancerous pericarditis, cancerous pleuritis, etc.). In this review, an overview of all studies conducted from 1985 to 2019 is provided.

Sign in / Sign up

Export Citation Format

Share Document